Impact BioMedical Inc. (IBO)
1.97
0.44 (28.76%)
At close: Feb 04, 2025, 3:59 PM
1.81
-8.02%
After-hours Feb 04, 2025, 05:38 PM EST
undefined% (undefined)
| Bid | 1.8 |
| Market Cap | 22.61M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | 0.1 |
| PE Ratio (ttm) | 19.65 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 2.1 |
| Volume | 17,968 |
| Avg. Volume (20D) | 37,040 |
| Open | 1.70 |
| Previous Close | 1.53 |
| Day's Range | 1.70 - 1.97 |
| 52-Week Range | 1.16 - 3.25 |
| Beta | undefined |
About IBO
Impact BioMedical Inc. engages in the discovery and development of products and treatment options in specialty biopharmaceuticals and consumer healthcare. It provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology; and Laetose technology that is derived from a unique combination of sugar and inositol, which can inhibit the inflammatory an...
Industry Biotechnology
Sector Healthcare
IPO Date n/a
Employees 1
Stock Exchange AMEX
Ticker Symbol IBO
Website https://www.impactbiomedinc.com
3 months ago
+19.2%
Impact BioMedical shares are trading higher after ...
Unlock content with
Pro Subscription